
Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2025 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
hepatitis C virus successfully treated with a triple-drug antiretroviral regimen are no more likely to experience rapid liver disease progression than adults infected only with HCV, according to a study in the January 15 edition of the journal Clinical Infectious Diseases. The researchers say early initiation of anti-HIV therapy reduces necroinflammation, which results in slower progressing and less severe liver disease. HIV coinfection can increase levels of hepatitis C virus in the bloodstream by 2- to 8-fold, French researchers reported in the November issue of the Journal of Hepatology. HIV-HCV coinfection also accelerates the risk of cirrhosis and of the rare but deadly condition fibrosing cholestatic hepatitis, they said. A study of nearly 5,000 HIV patients showed no evidence that any specific anti-HIV drug may be more poorly tolerated than others and lead to treatment discontinuation in study subjects also coinfected with HCV. Writing in the journal Antiviral Therapy, the researchers said their analysis has shown that while HIV-HCV'coinfected adults were more likely to quit therapy because of drug-related toxicity than those infected only with HIV, toxicity issues were not related to any specific anti-HIV medication. Blood-based levels of hepatitis C virus can predict the risks for end-stage liver disease and death in both patients infected only with HCV and in HIV-HCV'coinfected adults, according to a study in the December issue of the journal Hepatology. As HCV levels in the blood increased, so did the risk of death from end-stage liver disease, according to the study of nearly 400 HCV patients. Markers of liver damage that can be detected in the blood provide an accurate picture of the extent of liver disease in HIV-HCV'coinfected adults, according to a study in the December 15 edition of the Journal of Acquired Immune Deficiency Syndromes. They said their findings suggest these tests could be used in place of expensive and invasive liver biopsies. The FDA approved the hepatitis C treatment Ribasphere in December. The drug, jointly marketed by Par Pharmaceutical and Three Rivers Pharmaceuticals, is available in 200-, 400-, and 600-milligram tablets for use in combination with interferon alfa-2a. The FDA has granted fast-track review status to Vertex's experimental hepatitis C treatment VX-950. A Phase Ib study of the drug has shown it had significant and rapid virus-lowering effects. A Phase II U.S. study is expected to begin this year. Pharmaceutical firms Idenix and Novartis in January filed for FDA approval of their hepatitis B treatment telbivudine. A clinical trial including more than 1,300 hepatitis B patients showed telbivudine was more effective in suppressing HBV in the bloodstream than standard lamivudine therapy. Some hepatitis B test kits manufactured by Johnson & Johnson were recalled in January because of higher than normal odds of returning false-positive results. Three defective lots of the Vitros Immunodiagnostic HBsAG Confirmatory Kit had been distributed in Europe and the United States. Johnson & Johnson officials say they are unaware of anyone receiving an inaccurate diagnosis, but they urge health care facilities to review previous test results.
From our Sponsors
Most Popular
Lexi Love comes out as HIV+ after Trump deletes federal resources
January 23 2025 11:23 AM
Trump's orders prompt CDC to erase HIV resources
January 31 2025 5:29 PM
Grindr is reminding us why jockstraps are so sexy and iconic
May 02 2025 5:36 PM
BREAKING NEWS: Trump admin moves to end federal HIV prevention programs
March 18 2025 6:10 PM
This long-term HIV survivor says testosterone therapy helped save his life.
December 16 2024 8:00 PM
Discover the power of Wellness in your life
March 26 2025 12:41 PM
Celebrating Black History Month with our annual African American issue
February 01 2025 3:28 PM
Plus: Featured Video
Latest Stories
HRC holds 'die-in' to protest Trump health care cuts
April 28 2025 2:11 PM
Two right-wing Supreme Court justices signal they may uphold access to PrEP and more
April 21 2025 4:10 PM
500,000 Children at Risk: PEPFAR Funding Crisis
April 08 2025 3:51 PM
Broadway's best raise over $1 million for LGBTQ+ and HIV causes
April 03 2025 7:15 PM
The Talk Season 5 premieres this spring with HIV guidance for the newly diagnosed
March 26 2025 1:00 PM
Season 4 of The Switch on resilience & radical self-love returns this spring
March 26 2025 12:20 PM
Jess King is here to help you live your happiest, healthiest life yet
March 24 2025 4:35 PM
Gerald Garth is keeping people of color happy and healthy through trying times
March 11 2025 3:38 PM
Tyler TerMeer vows to continue to fight for health care for all
January 28 2025 3:00 PM
Plus nominated for 2025 GLAAD Media Award
January 22 2025 12:42 PM
A camp for HIV-positive kids is for sale. Here's why its founder is celebrating
January 02 2025 12:21 PM
'RuPaul's Drag Race' star Trinity K Bonet quietly comes out trans
December 15 2024 6:27 PM
Ricky Martin delivers showstopping performance for 2024 World AIDS Day
December 05 2024 12:08 PM
AIDS Memorial Quilt displayed at White House for the first time
December 02 2024 1:21 PM
Decades of progress, uniting to fight HIV/AIDS
December 01 2024 12:30 PM
Hollywood must do better on HIV representation
December 01 2024 9:00 AM
Climate change is disrupting access to HIV treatment
November 25 2024 11:05 AM